Newsroom

Sorted by: Latest

-

UMC Reports Sales for October 2026

TAIPEI, Taiwan--(BUSINESS WIRE)--United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”) today reported unaudited net sales for the month of October 2026. Revenues for October 2026 Period 2026 2025 Y/Y Change Y/Y (%) October 25,197,532 21,294,974 3,902,558 18.33% Jan.-Oct. 229,207,213 197,038,628 32,168,585 16.33% (*) All figures in thousands of New Taiwan Dollars (NT$), except for percentages. (**) All figures are consolidated Additional information about UMC is available on the we...
-

Dessalement : Veolia conforte sa position de leader avec des contrats d'envergure au Moyen-Orient

PARIS--(BUSINESS WIRE)--Regulatory News: Veolia (Paris:VIE) renforce son expansion et ses capacités au Moyen-Orient grâce à deux contrats majeurs dans le dessalement d'une valeur globale de près de 200 millions d'euros. Cette croissance comprend l'attribution du contrat d'exploitation de l’usine de dessalement d'Al Asilah en Oman pour cinq ans, ainsi que la mise en vigueur du projet de dessalement d'Al Hamriyah aux Émirats arabes unis dont Veolia fournira la technologie. Leader du secteur avec...
-

Desalination: Veolia Strengthens Its Position as a Global Leader With Major Contracts in the Middle East

PARIS--(BUSINESS WIRE)--Desalination: Veolia strengthens its position as a global leader with major contracts in the Middle East...
-

Experian and Vanquis Sign New Strategic Partnership to Improve Eligibility, Strengthen Fraud Prevention and Deliver Better Customer Outcomes

LONDON--(BUSINESS WIRE)--Experian, the global data and technology company, and Vanquis, one of the UK’s leading specialist finance providers, today announce a new strategic partnership designed to enhance customer eligibility assessment, help protect against fraud and support better customer outcomes. The multi-year collaboration will see Vanquis use Experian’s data, eligibility, and analytics services across its lending portfolio, including credit cards and vehicle finance, alongside advanced...
-

Next 15 Group plc UK Regulatory Announcement: Disposal

LONDON--(BUSINESS WIRE)--  NEXT 15 GROUP PLC (“Next 15” or the “Group”) Disposal of Marker Collective (“Marker”) to AVENIR GLOBAL (“AVENIR”) Further progress with the Group’s simplification strategy, unlocking significant value Next 15 Group plc announces that it has today completed the sale of Marker (comprising the businesses, Archetype, Outcast and Nectar Communications) to AVENIR for a total cash consideration of £70.4 million (the “Disposal”). Transaction highlights The Disposal values Mar...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  03-November-2026 Issue: Bank of Montréal Series 302 XS2552384930 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 10-August-2026 Date To: 10-November-2026 Record Date: 09-November-2026 Value Date: 10-November-2026 Benchmark Rate: 3.78629% Margin: 1.2% Total Rate: 4.98629% Number of Days: 92 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amount Due: USD 637,137.06 In...
-

Deutsche Bank AG UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  City Of Goteborg Issue of SEK 1,000,000,000.00 Floating Rate Green Bonds due February 2030 Series GB33 Tranche 1 MTN ISSUE NAME. Our Ref. MQ5999 ISIN Code. XS2761233191 TOTAL INTEREST AMT. CURRENCY CODE. SEK DAY BASIS. Actual/360 (A004) NUM OF DAYS. 94 INTEREST RATE. 2.915 PCT VALUE DATE. 08/02/2027 INTEREST PERIOD. 06/11/2026 TO 08/02/2027 SEK 7,611,388.89 POOL FACTOR. N/A...
-

Iksuda to Present First Clinical Data for IKS03 in Advanced B-Cell Non-Hodgkin Lymphomas at ASH

NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of class leading, antibody drug conjugates (ADCs), today announces the presentation of preliminary data from the dose escalation portion of its Phase 1 study of IKS03, a CD19-directed ADC, in patients with advanced B-cell non-Hodgkin lymphoma (B-NHL), at the 68th American Society of Hematology (ASH) Annual Meeting, December 12–15, 2026, New Orleans, Louisiana. As of 8 July 2026, 21 patients (median age 67 years) wi...
-

Mexedia S.p.A.: ADMISSION AUX NÉGOCIATIONS DES ACTIONS NOUVELLES ÉMISES AU TITRE DE LA PREMIÈRE TRANCHE DE L’AUGMENTATION DE CAPITAL RÉSERVÉE À LIKAN AG

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris : ALMEX, ISIN : IT0005450819, la « Société »), faisant suite à ses communiqués de presse des 28 et 29 octobre 2026, annonce l’admission aux négociations sur Euronext Growth Paris de 1 000 000 actions ordinaires nouvelles (les « Actions Nouvelles ») émises au titre de la première tranche de l’augmentation de capital réservée à Likan AG (l’« Investisseur »). L’Opération Comme annoncé au marché le 29 octo...
-

Mexedia S.p.A. : Admission to Trading of the New Shares Issued Under the First Tranche of the Capital Increase Reserved to Likan AG

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819, the “Company”), further to its press releases of 28 and 29 October 2026, announces the admission to trading on Euronext Growth Paris of 1,000,000 new ordinary shares (the “New Shares”) issued under the first tranche of the capital increase reserved to Likan AG (the “Investor”). The Transaction As announced to the market on 29 October 2026, the Company signed with the Investo...